| 000 | 01507 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514004505.0 | ||
| 264 | 0 | _c20020214 | |
| 008 | 200202s 0 0 eng d | ||
| 022 | _a0895-8696 | ||
| 024 | 7 |
_a10.1385/JMN:16:2-3:201 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLagarde, M | |
| 245 | 0 | 0 |
_aLysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain. _h[electronic resource] |
| 260 |
_bJournal of molecular neuroscience : MN _c |
||
| 300 |
_a201-4; discussion 215-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aBlood-Brain Barrier |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 |
_aDietary Fats, Unsaturated _xpharmacokinetics |
| 650 | 0 | 4 |
_aDocosahexaenoic Acids _xmetabolism |
| 650 | 0 | 4 |
_aFish Oils _xpharmacokinetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLysophosphatidylcholines _xmetabolism |
| 650 | 0 | 4 |
_aPhosphatidylcholines _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSerum Albumin _xmetabolism |
| 650 | 0 | 4 |
_aTriglycerides _xmetabolism |
| 700 | 1 | _aBernoud, N | |
| 700 | 1 | _aBrossard, N | |
| 700 | 1 | _aLemaitre-Delaunay, D | |
| 700 | 1 | _aThiès, F | |
| 700 | 1 | _aCroset, M | |
| 700 | 1 | _aLecerf, J | |
| 773 | 0 |
_tJournal of molecular neuroscience : MN _gvol. 16 _gno. 2-3 _gp. 201-4; discussion 215-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1385/JMN:16:2-3:201 _zAvailable from publisher's website |
| 999 |
_c11405602 _d11405602 |
||